Rare diseases

https://pharmaphorum.com/partner-content/three-interactive-sessions-to-take-place-at-the-respiratory-drug-delivery-conference/

Achieving launch excellence in orphan medicines

https://pharmaphorum.com/market-access-2/achieving-launch-excellence-in-orphan-medicines/

Under threat from Novartis, Biogen hails new data from SMA drug Spinraza

https://pharmaphorum.com/news/under-threat-from-novartis-biogen-hails-new-data-from-sma-drug-spinraza/

Alexion Pharmaceuticals & Minoryx Therapeutics to Present at SMi’s Orphan Drugs Event

https://pharmaphorum.com/partner-content/alexion-pharmaceuticals-minoryx-therapeutics-to-present-at-smis-orphan-drugs-event/

Alexion’s Soliris gets new, and lucrative, rare disease indication

https://pharmaphorum.com/news/alexions-soliris-gets-new-and-lucrative-rare-disease-indication/

Spain’s Sanifit raises €72 million for rare disease drug trial

https://pharmaphorum.com/news/spains-sanifit-raises-e72-million-for-rare-disease-drug-trial/

NICE backs Alimera’s three-year uveitis implant

https://pharmaphorum.com/news/nice-backs-alimeras-three-year-uveitis-implant/

Bringing gene therapies to market

https://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/bluebird-bio-gene-therapies-market/

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

https://pharmaphorum.com/partner-content/invitation-to-smis-orphan-drugs-rare-diseases-conference-2019/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search